11870 related articles for article (PubMed ID: 11293263)
1. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
2. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
3. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth.
Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A
Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide.
Wietrzyk J; Boratynski J; Grynkiewicz G; Ryczynski A; Radzikowski C; Opolski A
Anticancer Res; 2001; 21(6A):3893-6. PubMed ID: 11911265
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
[TBL] [Abstract][Full Text] [Related]
8. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
[TBL] [Abstract][Full Text] [Related]
10. [Modulation of the antitumor effect of cyclophosphamide by the recombinant probiotic Subalin].
Cherdyntseva NV; Litviakov NV; Smol'ianinov ES; Beliavskaia VA; Masycheva VI
Vopr Onkol; 1997; 43(3):313-6. PubMed ID: 9245089
[TBL] [Abstract][Full Text] [Related]
11. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats].
Komatsumoto M; Li S; Hamada J; Takeichi N; Hosokawa M; Okayasu T; Tanabe T; Kobayashi H
Gan To Kagaku Ryoho; 1988 May; 15(5):1739-45. PubMed ID: 3130810
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
14. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
[TBL] [Abstract][Full Text] [Related]
16. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
[TBL] [Abstract][Full Text] [Related]
17. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents.
Holden SA; Lan Y; Pardo AM; Wesolowski JS; Gillies SD
Clin Cancer Res; 2001 Sep; 7(9):2862-9. PubMed ID: 11555604
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
Youn JK; Lacour F; Hue G
Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.
Konovalova NP; Diatchkovskaya RF; Volkova LM; Kagiya TV
Neoplasma; 1995; 42(3):119-22. PubMed ID: 7637820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
